--- title: How Covering GLP-1 Receptor Agonists Can Enhance Workforce Health description: Discover how GLP-1 weight loss drugs can have a large impact on overall employee health and how these positive impacts extend to the company as a whole. image: https://blog.valenzhealth.com/hubfs/Blog/AdobeStock_1037289032%20(1)-1.jpeg --- [Skip to content](https://blog.valenzhealth.com/how-covering-glp-1-receptor-agonists-can-enhance-workforce-health#page-content) [![Valenz Health](https://blog.valenzhealth.com/hubfs/web/logo.svg)](https://www.valenzhealth.com/) - [Who We Serve](https://www.valenzhealth.com/who-we-serve/) - [Solutions](https://www.valenzhealth.com/solutions/member-experience/) - [About Us](https://www.valenzhealth.com/about-us/) - [Resources](https://www.valenzhealth.com/resources/) - [Contact](https://www.valenzhealth.com/contact/) ### [Patients](https://www.valenzhealth.com/who-we-serve/members/) ### Payers - [Employers](https://www.valenzhealth.com/who-we-serve/employers/) - [Taft-Hartley Funds](https://www.valenzhealth.com/who-we-serve/taft-hartley-funds/) ### Providers - [Healthcare Facilities and Providers](https://www.valenzhealth.com/who-we-serve/healthcare-facilities-and-providers/) ### Plans - [Health Plans](https://www.valenzhealth.com/who-we-serve/health-plans/) - [Third-Party Administrators](https://www.valenzhealth.com/who-we-serve/third-party-administrators-tpas/) - [Brokers and Consultants](https://www.valenzhealth.com/who-we-serve/brokers/) - [Stop Loss Producers](https://www.valenzhealth.com/who-we-serve/stop-loss-producers/) #### Partner with Us Discover how Vālenz Health® can simplify the healthcare experience with our innovative solutions. [Explore All](https://www.valenzhealth.com/who-we-serve/) ### Member Experience - [Overview](https://www.valenzhealth.com/solutions/member-experience/) - [Clinical Engagement](https://www.valenzhealth.com/solutions/member-experience/clinical-engagement/) - [Valenz Bluebook](https://www.valenzhealth.com/solutions/member-experience/valenz-bluebook/) - - [Bluebook Rx](https://www.valenzhealth.com/solutions/member-experience/bluebook-rx/) - [Surgical and Imaging](https://www.valenzhealth.com/solutions/member-experience/surgical-imaging/) - [Infusion Therapy](https://www.valenzhealth.com/solutions/member-experience/infusion-therapy/) ### Payment Integrity - [Overview](https://www.valenzhealth.com/solutions/payment-integrity/) - [ABN Medical Necessity](https://www.valenzhealth.com/solutions/payment-integrity/abn-medical-necessity-validation/) - [Clean Claim Verification](https://www.valenzhealth.com/solutions/payment-integrity/clean-claim-verification/) - [Bill Review](https://www.valenzhealth.com/solutions/payment-integrity/clinical-bill-review/) - [Curated Data Sources](https://www.valenzhealth.com/solutions/payment-integrity/curated-data-sources/) - [In-Network Repricing](https://www.valenzhealth.com/solutions/payment-integrity/in-network-repricing/) - [Out-of-Network Repricing](https://www.valenzhealth.com/solutions/payment-integrity/out-of-network-repricing/) ### Provider Quality - [Overview](https://www.valenzhealth.com/solutions/provider-quality/) - [Credentialing](https://www.valenzhealth.com/solutions/provider-quality/credentialing/) - [Provider Staff Sanction Monitoring](https://www.valenzhealth.com/solutions/provider-quality/provider-staff-sanction-monitoring/) - [CareChex® Awards](https://www.valenzhealth.com/solutions/provider-quality/carechex-awards-by-quantros/) - [Outcomes Analytics by Quantros](https://www.valenzhealth.com/solutions/provider-quality/outcomes-analytics/) ### Plan Performance - [Overview](https://www.valenzhealth.com/solutions/plan-performance/) - [Stop Loss](https://www.valenzhealth.com/solutions/plan-performance/stop-loss/) - [Variable Copay](https://www.valenzhealth.com/solutions/plan-performance/variable-copay/) ### Platform - [Integrated Platform](https://www.valenzhealth.com/solutions/integrated-platform/) #### Solution Finder Find the right solution for your needs. [Get Started](https://www.valenzhealth.com/solutions/) ### Company - [About Valenz Health](https://www.valenzhealth.com/about-us/) - [Careers](https://www.valenzhealth.com/about-us/careers/) ### Why Valenz - [Leadership Team](https://www.valenzhealth.com/about-us/#Executive-Leadership) - [Our Mission](https://www.valenzhealth.com/about-us/#About-Valenz-Health) - [Our Values](https://www.valenzhealth.com/about-us/#Core-Values) #### Join Our Team Be part of the healthcare revolution. We're hiring talented individuals who share our vision. [View Open Positions](https://www.valenzhealth.com/about-us/careers/) ### Regulatory & Compliance - [The No Surprises Act (NSA)](https://www.valenzhealth.com/resources/no-surprises-act/) - [Transparency in Coverage (TiC)](https://www.valenzhealth.com/resources/transparency-in-coverage/) - [OIG Compliance](https://www.valenzhealth.com/resources/oig-compliance/) ### Industry Insights - [Fighting Fraud, Waste, and Abuse](https://www.valenzhealth.com/resources/fraud-waste-abuse/) - [Self-Funded Insurance](https://www.valenzhealth.com/resources/self-funded-health-insurance/) #### Resource Center Stay informed with our latest whitepapers, guides, and industry insights. [Browse All Resources](https://www.valenzhealth.com/resources/) [![Valenz Health](https://blog.valenzhealth.com/hubfs/web/logo.svg)](https://www.valenzhealth.com/) - Who We Serve - Solutions - About Us - Resources - Contact Us - Login - Search Back ### Who We Serve - [Overview](https://www.valenzhealth.com/who-we-serve/) #### Patients - [Members](https://www.valenzhealth.com/who-we-serve/members/) #### Payers - [Employers](https://www.valenzhealth.com/who-we-serve/employers/) - [Taft-Hartley Funds](https://www.valenzhealth.com/who-we-serve/taft-hartley-funds/) #### Providers - [Healthcare Facilities and Providers](https://www.valenzhealth.com/who-we-serve/healthcare-facilities-and-providers/) #### Plans - [Health Plans](https://www.valenzhealth.com/who-we-serve/health-plans/) - [Third-Party Administrators](https://www.valenzhealth.com/who-we-serve/third-party-administrators-tpas/) - [Brokers and Consultants](https://www.valenzhealth.com/who-we-serve/brokers/) - [Stop Loss Producers](https://www.valenzhealth.com/who-we-serve/stop-loss-producers/) Back ### Solutions - [Overview](https://www.valenzhealth.com/solutions/) - [Member Experience](https://www.valenzhealth.com/solutions/member-experience/) - [Payment Integrity](https://www.valenzhealth.com/solutions/payment-integrity/) - [Provider Quality](https://www.valenzhealth.com/solutions/provider-quality/) - [Plan Performance](https://www.valenzhealth.com/solutions/plan-performance/) - [Platform](https://www.valenzhealth.com/solutions/integrated-platform/) Back ### About Us - [Overview](https://www.valenzhealth.com/about-us/) - [Careers](https://www.valenzhealth.com/about-us/careers/) Back ### Resources - [Overview](https://www.valenzhealth.com/resources/) - [The No Surprises Act (NSA)](https://www.valenzhealth.com/resources/no-surprises-act/) - [Transparency in Coverage (TiC)](https://www.valenzhealth.com/resources/transparency-in-coverage/) - [Office of Inspector General Compliance](https://www.valenzhealth.com/resources/oig-compliance/) - [Fighting Fraud, Waste, and Abuse (FWA)](https://www.valenzhealth.com/resources/fraud-waste-abuse/) - [Self-Funded Insurance](https://www.valenzhealth.com/resources/self-funded-health-insurance/) Back ### Payment Integrity - [Overview](https://www.valenzhealth.com/solutions/payment-integrity/) - [ABN Medical Necessity Validation](https://www.valenzhealth.com/solutions/payment-integrity/abn-medical-necessity-validation/) - [Clean Claim Verification](https://www.valenzhealth.com/solutions/payment-integrity/clean-claim-verification/) - [Bill Review](https://www.valenzhealth.com/solutions/payment-integrity/clinical-bill-review/) - [Curated Data Sources](https://www.valenzhealth.com/solutions/payment-integrity/curated-data-sources/) - [In-Network Repricing](https://www.valenzhealth.com/solutions/payment-integrity/in-network-repricing/) - [Out-of-Network Repricing](https://www.valenzhealth.com/solutions/payment-integrity/out-of-network-repricing/) Back ### Provider Quality - [Overview](https://www.valenzhealth.com/solutions/provider-quality/) - [Credentialing](https://www.valenzhealth.com/solutions/provider-quality/credentialing/) - [Provider Staff Sanction Monitoring](https://www.valenzhealth.com/solutions/provider-quality/provider-staff-sanction-monitoring/) - [CareChex® Awards by Quantros](https://www.valenzhealth.com/solutions/provider-quality/carechex-awards-by-quantros/) - [Outcomes Analytics by Quantros](https://www.valenzhealth.com/solutions/provider-quality/outcomes-analytics/) Back ### Member Experience - [Overview](https://www.valenzhealth.com/solutions/member-experience/) - [Clinical Engagement](https://www.valenzhealth.com/solutions/member-experience/clinical-engagement/) - [Valenz Bluebook](https://www.valenzhealth.com/solutions/member-experience/valenz-bluebook/) - [• Bluebook Rx](https://www.valenzhealth.com/solutions/member-experience/bluebook-rx/) - [Precision Care](https://www.valenzhealth.com/solutions/member-experience/valenz-bluebook/#precision-care/) Back ### Plan Performance - [Overview](https://www.valenzhealth.com/solutions/plan-performance/) - [Stop Loss](https://www.valenzhealth.com/solutions/plan-performance/stop-loss/) - [Variable Copay](https://www.valenzhealth.com/solutions/plan-performance/variable-copay/) Back ### Search # How Covering GLP-1 Receptor Agonists Can Enhance Workforce Health By [Vālenz Health®](https://blog.valenzhealth.com/author/valenz-health) - January 09, 2025 [Pharmacy and Prescription Drugs](https://blog.valenzhealth.com/tag/pharmacy-and-prescription-drugs) [GLP-1s](https://blog.valenzhealth.com/tag/glp-1s) Share ![A diverse group of employees meet in a conference room. ](https://blog.valenzhealth.com/hs-fs/hubfs/Blog/AdobeStock_1037289032%20(1)-1.jpeg?width=485&height=485&name=AdobeStock_1037289032%20(1)-1.jpeg) As the use of glucagon-like peptide-1 (GLP-1) receptor agonist drugs has increased, the demand for health plans to cover them has also increased, and it’s easy to see why. GLP-1 weight loss drugs can have a significant impact on health, helping people manage their weight while reducing the risk of chronic conditions that can arise from obesity. By covering GLP-1s, employers can significantly improve their overall workforce health, leading to improved health outcomes and productivity and reduced healthcare costs. Employers can invest in employee health while containing costs by implementing solutions like Vālenz Health®, and its pharmacy program, [Valenz Bluebook Rx](https://www.valenzhealth.com/solutions/member-experience/bluebook-rx/). ## How GLP-1 Weight Loss Drugs Can Help Improve Workforce Health GLP-1s have a significant impact on the lives of the people taking them, but they aren’t the only ones who experience the positive impacts. Their employers also experience the benefits of their workforce becoming healthier.  Here are just some of the ways GLP-1 weight loss drugs can have a positive impact on your overall workforce: ### Improved Health GLP-1s can help people lose [15–20%](https://pubmed.ncbi.nlm.nih.gov/36321278/) of their body weight, which is a range that was only previously achievable through bariatric surgery. This has a significant impact on metabolic health, can help people with type 2 diabetes, and may reduce the risk of chronic diseases arising from obesity or diabetes. For example, GLP-1s can help reduce the risk of chronic conditions such as high cholesterol, high blood pressure, diabetes, heart disease, heart failure, and kidney disease. Additionally, [GLP-1 research](https://pmc.ncbi.nlm.nih.gov/articles/PMC8775408/) has expanded into several other areas, including research into Alzheimer’s disease, nonalcoholic fatty liver disease, Parkinson’s disease, and more. ### Improved Productivity and Performance Employees who are [managing their weight with GLP-1s](https://blog.valenzhealth.com/investing-in-health-employer-coverage-of-glp-1-weight-loss-drugs) may experience increased energy levels, better focus, and improved job performance. This can also have a large impact on reducing absenteeism and decreasing indirect costs from lost productivity due to specialist visits or illness. Additionally, [two-thirds](https://www.shrm.org/topics-tools/news/benefits-compensation/employers-covering-glp1-drugs-could-nearly-double-in-2024-accolade-weight-loss-ozempic-wegovy) of organizations that have decided to cover GLP-1s have experienced an increased health plan enrollment, which has translated to greater employee satisfaction. ### Lower Healthcare Costs It’s well-known that GLP-1 weight loss drugs are costly, and this can be a significant barrier for both covering the medication and using it. The annual cost of GLP-1s per member can exceed [$11,000](https://www.kff.org/policy-watch/medicare-spending-on-ozempic-and-other-glp-1s-is-skyrocketing/). However, the larger impact GLP-1s have on improving overall health and reducing the risk of chronic conditions can make bearing the cost of GLP-1s worth it by reducing long-term costs for conditions that arise from obesity and the medications required to treat those conditions. ### Positive Impact on Mental Health Achieving weight loss goals by using GLP-1s has the potential to improve mental health, boost mood and self-esteem, and lead to an overall [enhanced quality of life](https://blog.valenzhealth.com/the-impact-of-glp-1-weight-loss-drugs-on-workforce-health-a-comprehensive-overview), which can significantly impact personal outlook. Additionally, managing chronic conditions and reducing the potential for expensive prescriptions and specialist visits can lead to financial relief.  Financial problems stemming from chronic conditions can have an impact on a person’s lifestyle, aspirations, employment, and, most notably, their stress levels. [Approximately 60% of adults in the U.S.](https://www.apa.org/news/press/releases/2018/01/insurance-costs) state that health concerns or health problems are a significant source of stress. Addressing the root of these problems by providing coverage for medications such as GLP-1s that address obesity, diabetes, and chronic conditions that result from both can have a large impact on employees’ mood and mental health.   ## How to Address Pharmacy Spend on GLP-1s and Other Medications As beneficial as GLP-1 weight loss drugs are for employee health, the cost can be a deterrent to employer coverage. This is why programs such as [Valenz Bluebook Rx](https://www.valenzhealth.com/solutions/member-experience/bluebook-rx/) are such a critical strategy for [reducing costs](https://blog.valenzhealth.com/employers-guide-to-integrating-glp-1s-into-health-benefits-packages). Valenz Bluebook Rx helps employers and members save by identifying overpriced treatments and recommending lower-cost alternatives. This extends to GLP-1s. A recent expansion to Valenz Bluebook Rx addresses the high cost of GLP-1s, providing a bundled solution that allows organizations and their employees to lower GLP-1 drug costs. ## Employee Health vs. Managing Costs: You Don’t Have to Choose Prioritizing employee health while managing costs is a delicate balancing act. With solutions like Valenz and its pharmacy program, Valenz Bluebook Rx, you can invest in your employees’ health while helping manage costs for both them and your organization. Learn how other companies have managed costs — and unlock your plan's potential savings — by contacting our team today. ### Connect with Us to Learn More   ![Vālenz Health®](https://blog.valenzhealth.com/hs-fs/hubfs/Valenz%20Logo%20Signature.png?width=48&height=48&name=Valenz%20Logo%20Signature.png) [Vālenz Health®](https://blog.valenzhealth.com/author/valenz-health) Vālenz Health® empowers employers, brokers, payers, and providers to reduce costs, improve quality, and elevate the healthcare experience. Our solutions combine advanced technology, clinical expertise, and extensive cost, quality, and utilization datasets to execute across the entire healthcare journey — connecting insights and action for greater transparency, flexibility, and cost containment within a complex system. By helping our customers and members navigate healthcare with confidence, we support smarter care decisions, strengthen plan performance, and deliver better value for everyone we serve. ## Related Articles [![A woman with a chronic health condition takes medication while sitting at a desk. ](https://blog.valenzhealth.com/hubfs/Blog/AdobeStock_600720024%20(1)-1.jpeg)](https://blog.valenzhealth.com/health-conditions-driving-up-healthcare-costs) ### [The Health Conditions Driving Up Healthcare Costs — and What Employers Can Do About Them](https://blog.valenzhealth.com/health-conditions-driving-up-healthcare-costs) For the second year in a row, healthcare costs are expected to rise by 9% for the group market in the United States, according to the latest research by PWC. [Trista Taylor](https://blog.valenzhealth.com/author/trista-taylor) July 02, 2026 [![A female patient holding an injection.](https://blog.valenzhealth.com/hubfs/Blog/AdobeStock_717197856%20(1)-1.jpeg)](https://blog.valenzhealth.com/weighing-the-costs-how-glp-1-weight-loss-drugs-can-save-employers-money-in-the-long-run) ### [Weighing the Costs: How GLP-1 Weight Loss Drugs Can Save Employers Money in the Long Run](https://blog.valenzhealth.com/weighing-the-costs-how-glp-1-weight-loss-drugs-can-save-employers-money-in-the-long-run) The popularity of glucagon-like peptide-1 (GLP-1) weight loss drugs is on the rise, offering transformative health benefits for those struggling with obesity. For employers, these medications present a unique opportunity to improve employee well-being while addressing the substantial financial implications of chronic health conditions. [Vālenz Health®](https://blog.valenzhealth.com/author/valenz-health) January 30, 2025 Share Ready to Simplify Self-Insurance? ## Your Journey Starts Here Connect with a Valenz team member to explore the difference our solutions can make for you. ![Vālenz Health](https://www.valenzhealth.com/wp-content/uploads/2025/05/logo.svg) [![Youtube](https://www.valenzhealth.com/wp-content/uploads/2025/06/Icon-Youtube.svg)](https://www.youtube.com/@valenzhealth) [![Linkedin](https://www.valenzhealth.com/wp-content/uploads/2025/06/Icon-Linkedin.svg)](https://www.linkedin.com/company/valenz/) [Login](https://www.valenzhealth.com/user-login/) [Help Center](https://support.valenzhealth.com/hc/en-us) [Trust Center](https://trust.valenzhealth.com/) [Privacy Policy](https://www.valenzhealth.com/privacy-policy/) Cookie Settings [Cookie Policy](https://www.valenzhealth.com/cookie-policy/) [California Privacy Rights Notice](https://www.valenzhealth.com/california-privacy-rights-notice/) [Terms and Conditions](https://www.valenzhealth.com/terms-and-conditions/) 1717 McKinney Ave, Suite 1000, Dallas, TX 75202, USA | [(866) 762-4455](tel:+18667624455) © 2026 Vālenz Health® ```json { "@context" : "https://schema.org", "@type" : "BlogPosting", "about" : [ { "@type" : "Thing", "name" : "Pharmacy and Prescription Drugs" }, { "@type" : "Thing", "name" : "GLP-1s" } ], "articleBody" : "As the use of glucagon-like peptide-1 (GLP-1) receptor agonist drugs has increased, the demand for health plans to cover them has also increased, and it’s easy to see why. GLP-1 weight loss drugs can have a significant impact on health, helping people manage their weight while reducing the risk of chronic conditions that can arise from obesity. By covering GLP-1s, employers can significantly improve their overall workforce health, leading to improved health outcomes and productivity and reduced healthcare costs. Employers can invest in employee health while containing costs by implementing solutions like Vālenz Health®, and its pharmacy program, Valenz Bluebook Rx. How GLP-1 Weight Loss Drugs Can Help Improve Workforce Health GLP-1s have a significant impact on the lives of the people taking them, but they aren’t the only ones who experience the positive impacts. Their employers also experience the benefits of their workforce becoming healthier. Here are just some of the ways GLP-1 weight loss drugs can have a positive impact on your overall workforce: Improved Health GLP-1s can help people lose 15–20% of their body weight, which is a range that was only previously achievable through bariatric surgery. This has a significant impact on metabolic health, can help people with type 2 diabetes, and may reduce the risk of chronic diseases arising from obesity or diabetes. For example, GLP-1s can help reduce the risk of chronic conditions such as high cholesterol, high blood pressure, diabetes, heart disease, heart failure, and kidney disease. Additionally, GLP-1 research has expanded into several other areas, including research into Alzheimer’s disease, nonalcoholic fatty liver disease, Parkinson’s disease, and more. Improved Productivity and Performance Employees who are managing their weight with GLP-1s may experience increased energy levels, better focus, and improved job performance. This can also have a large impact on reducing absenteeism and decreasing indirect costs from lost productivity due to specialist visits or illness. Additionally, two-thirds of organizations that have decided to cover GLP-1s have experienced an increased health plan enrollment, which has translated to greater employee satisfaction. Lower Healthcare Costs It’s well-known that GLP-1 weight loss drugs are costly, and this can be a significant barrier for both covering the medication and using it. The annual cost of GLP-1s per member can exceed $11,000. However, the larger impact GLP-1s have on improving overall health and reducing the risk of chronic conditions can make bearing the cost of GLP-1s worth it by reducing long-term costs for conditions that arise from obesity and the medications required to treat those conditions. Positive Impact on Mental Health Achieving weight loss goals by using GLP-1s has the potential to improve mental health, boost mood and self-esteem, and lead to an overall enhanced quality of life, which can significantly impact personal outlook. Additionally, managing chronic conditions and reducing the potential for expensive prescriptions and specialist visits can lead to financial relief. Financial problems stemming from chronic conditions can have an impact on a person’s lifestyle, aspirations, employment, and, most notably, their stress levels. Approximately 60% of adults in the U.S. state that health concerns or health problems are a significant source of stress. Addressing the root of these problems by providing coverage for medications such as GLP-1s that address obesity, diabetes, and chronic conditions that result from both can have a large impact on employees’ mood and mental health. How to Address Pharmacy Spend on GLP-1s and Other Medications As beneficial as GLP-1 weight loss drugs are for employee health, the cost can be a deterrent to employer coverage. This is why programs such as Valenz Bluebook Rx are such a critical strategy for reducing costs. Valenz Bluebook Rx helps employers and members save by identifying overpriced treatments and recommending lower-cost alternatives. This extends to GLP-1s. A recent expansion to Valenz Bluebook Rx addresses the high cost of GLP-1s, providing a bundled solution that allows organizations and their employees to lower GLP-1 drug costs. Employee Health vs. Managing Costs: You Don’t Have to Choose Prioritizing employee health while managing costs is a delicate balancing act. With solutions like Valenz and its pharmacy program, Valenz Bluebook Rx, you can invest in your employees’ health while helping manage costs for both them and your organization. Learn how other companies have managed costs — and unlock your plan's potential savings — by contacting our team today. Connect with Us to Learn More", "articleSection" : [ "How GLP-1 Weight Loss Drugs Can Help Improve Workforce Health", "Improved Health", "Improved Productivity and Performance", "Lower Healthcare Costs", "Positive Impact on Mental Health", "How to Address Pharmacy Spend on GLP-1s and Other Medications", "Employee Health vs. Managing Costs: You Don’t Have to Choose" ], "author" : { "@id" : "https://blog.valenzhealth.com/author/valenz-health", "@type" : "Person", "name" : "Vālenz Health®", "url" : "https://blog.valenzhealth.com/author/valenz-health" }, "dateModified" : "2025-12-18T11:47:47-05:00", "datePublished" : "2025-01-09T13:14:27-05:00", "description" : "Discover how GLP-1 weight loss drugs can have a large impact on overall employee health and how these positive impacts extend to the company as a whole.", "headline" : "How Covering GLP-1 Receptor Agonists Can Enhance Workforce Health", "image" : "https://1769848.fs1.hubspotusercontent-na1.net/hubfs/1769848/Blog/AdobeStock_1037289032%20%281%29-1.jpeg", "mainEntityOfPage" : { "@id" : "https://blog.valenzhealth.com/how-covering-glp-1-receptor-agonists-can-enhance-workforce-health", "@type" : "WebPage" }, "publisher" : { "@id" : "https://www.valenzhealth.com/", "@type" : "Organization", "areaServed" : "United States of America (USA)", "contactPoint" : { "@type" : "ContactPoint", "areaServed" : "United States of America (USA)", "availableLanguage" : [ "English" ], "contactType" : "Customer Service", "email" : "info@valenzhealth.com", "telephone" : "866-762-4455", "url" : "https://www.valenzhealth.com/contact/" }, "logo" : { "@type" : "ImageObject", "url" : "https://blog.valenzhealth.com/hubfs/web/logo.svg" }, "name" : "Vālenz Health®", "sameAs" : [ "https://www.youtube.com/@valenzhealth", "https://www.linkedin.com/company/valenz/" ], "url" : "https://www.valenzhealth.com/" }, "url" : "https://blog.valenzhealth.com/how-covering-glp-1-receptor-agonists-can-enhance-workforce-health", "wordCount" : 760 } ```